Drugs logo Adis International logo

Publisher: Adis International

Volume 70, Number 2, 22 January 2010
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | all issues

Therapy In Practice

Content loaded within last 14 days Optimizing the Use of Tumour Necrosis Factor Inhibitors in Crohn's Disease: A Practical Approach
pp. 109-120(12)
Authors: >Maria Josefina Etchevers,; Ordás, Ingrid; Ricart, Elena

Review Articles

Content loaded within last 14 days Management of Patients with Advanced Non-Small Cell Lung Cancer: Current and Emerging Options
pp. 167-179(13)
Authors: Triano, Laura R.; Deshpande, Hari; Gettinger, Scott N.

Adis Drug Profile

Content loaded within last 14 days Bevacizumab: In Previously Treated Glioblastoma
pp. 181-189(9)
Author: Moen, Marit D.

Adis Drug Evaluations

Content loaded within last 14 days Trastuzumab: A Review of its Use as Adjuvant Treatment in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer
pp. 215-239(25)
Authors: Garnock-Jones, Karly P.; Keating, Gillian M.; Scott, Lesley J.

< previous issue | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A